2.405
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt FBIO?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$2.56
Offen:
$2.57
24-Stunden-Volumen:
235.97K
Relative Volume:
0.24
Marktkapitalisierung:
$71.41M
Einnahmen:
$80.97M
Nettoeinkommen (Verlust:
$-78.31M
KGV:
-0.217
EPS:
-11.0849
Netto-Cashflow:
$-129.56M
1W Leistung:
-6.23%
1M Leistung:
-12.37%
6M Leistung:
+31.69%
1J Leistung:
+26.84%
Fortress Biotech Inc Stock (FBIO) Company Profile
Firmenname
Fortress Biotech Inc
Sektor
Branche
Telefon
781-652-4500
Adresse
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY
Vergleichen Sie FBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
FBIO
Fortress Biotech Inc
|
2.40 | 76.17M | 80.97M | -78.31M | -129.56M | -11.08 |
|
VRTX
Vertex Pharmaceuticals Inc
|
420.04 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.60 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.37 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
811.55 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
179.87 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-15 | Fortgesetzt | ROTH MKM | Buy |
| 2022-08-04 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2020-10-02 | Eingeleitet | The Benchmark Company | Buy |
| 2019-12-18 | Eingeleitet | B. Riley FBR | Buy |
| 2018-02-28 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-07-11 | Eingeleitet | Rodman & Renshaw | Buy |
| 2017-03-22 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2016-10-03 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Fortress Biotech Inc Aktie (FBIO) Neueste Nachrichten
How Fortress Biotech Inc. stock benefits from tech adoptionJuly 2025 Price Swings & Expert Curated Trade Setup Alerts - newser.com
Can Fortress Biotech Inc. stock attract ESG capital inflowsEarnings Trend Report & Reliable Entry Point Trade Alerts - newser.com
Can a trend reversal in Fortress Biotech Inc. lead to recoveryBreakout Watch & Verified Technical Trade Signals - newser.com
Can Fortress Biotech Inc. stock double in next 5 yearsJuly 2025 Outlook & Technical Pattern Based Buy Signals - newser.com
Is Fortress Biotech Inc. stock reversal real or fakeJuly 2025 PostEarnings & Advanced Swing Trade Entry Plans - newser.com
Should I hold or sell Fortress Biotech Inc. stock in 2025Earnings Growth Report & Long-Term Growth Portfolio Plans - newser.com
Why Fortress Biotech Inc. stock could be next big winnerWeekly Stock Recap & Consistent Growth Stock Picks - newser.com
Exit strategy if you’re trapped in Fortress Biotech Inc. - newser.com
What earnings revisions data tells us about Fortress Biotech Inc.2025 Trading Recap & Risk Controlled Swing Alerts - newser.com
Developing predictive dashboards with Fortress Biotech Inc. dataJuly 2025 Pullbacks & Weekly Market Pulse Updates - newser.com
Will Fortress Biotech Inc. stock maintain momentum in 2025July 2025 Snapshot & AI Powered Market Entry Ideas - fcp.pa.gov.br
Is Fortress Biotech Inc. stock positioned well for digital economyOptions Play & Community Verified Trade Signals - fcp.pa.gov.br
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc.FBIO - WV News
Little Excitement Around Fortress Biotech, Inc.'s (NASDAQ:FBIO) Revenues As Shares Take 34% Pounding - 富途牛牛
What high frequency data says about Fortress Biotech Inc.July 2025 Pullbacks & Expert Verified Movement Alerts - newser.com
Buyback Watch: Can Fortress Biotech Inc. stock outperform in 2025 bull marketTreasury Yields & Community Consensus Picks - Fundação Cultural do Pará
Weiss Ratings Reiterates Sell (D-) Rating for Fortress Biotech (NASDAQ:FBIO) - MarketBeat
Finanzdaten der Fortress Biotech Inc-Aktie (FBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):